Todos Med Ltd (TOMDF)

[JoeForkeyBolo]

Todos Medical updates on Phase 2 trial progress to treat hospitalized coronavirus patients in Israel

Video Link:
https://www.proactiveinvestors.com/companies/news/955174/todos-medical-updates-on-phase-2-trial-progress-to-treat-hospitalized-coronavirus-patients-in-israel-955174.html

Todos Medical Ltd (OTCQB:TOMDF) CEO Gerald Commissiong updated Proactive on progress of enrollment of its Phase 2 clinical trial to treat hospitalized coronavirus patients in Israel, with its TolloTest biomarker being used for the first time as a surrogate biomarker to monitor patient response to treatment.

Commissiong says recruitment is 'picking up again' due to an increase in coronavirus caseload in Israel.

The medical diagnostics and related solutions company also said its partners at NLC Pharma have identified an anti-inflammatory mechanism of action for its Tollovir dietary supplement to complement its 3CL protease inhibiting mechanism. Tollovid, a mix of botanical extracts, is being targeted to support healthy immune function against circulating coronaviruses.